Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Completed
Trial end date:
2004-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Suramin may stop the growth of glioblastoma multiforme by stopping blood flow to
the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining suramin
with radiation therapy may be a more effective treatment for glioblastoma multiforme.
PURPOSE: Phase II trial to study the effectiveness of suramin plus radiation therapy in
treating patients who have newly diagnosed glioblastoma multiforme.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins